# Boston Scientific Corporation (BSX) — Q2-2019 Earnings Results

**Report date:** 2019-07-24 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BSX/earnings/Q2-2019

## Post-Earnings Brief

### Headline

Boston Scientific Misses on EPS, Stock Down 0.02%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.39 | N/A | -0.19% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed a cautious optimism about future growth despite current market challenges. They emphasized their commitment to innovation.

**Key quotes:**

> Management highlighted ongoing investments in innovation and product development.

> They noted challenges in certain markets but remain focused on long-term growth.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Boston Scientific's earnings report showed a slight miss on EPS, which may indicate some pressure on profitability. The stock reacted minimally, down just 0.02%, suggesting that investors may have anticipated the results. Management's focus on innovation and long-term growth could provide a positive outlook, but the lack of revenue data leaves some uncertainty.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BSX/earnings/Q2-2019_